COVID-19 Records

Transcript segment

Baric Transcribed Interview (Redacted), p.20 · baric_ti:utt:00104

Page text: p.20 · original PDF

Date
2026-04-10 09:00 (day precision)
Type
transcript segment · interview
recipient
Ralph S. Baric, Harry Kazenoff, David T. Lambeth III, William Henderson, Clark Ervin, Jake Greenberg
speaker
Christina Salazar
But for all coronaviruses? For flu?

In context

A single line often inverts meaning once you see what it answers, so neighbouring messages are always shown.

  1. 2026-04-10 09:00 Christina Salazar open
    And so what information did you have from the paper? DC.Scheduling@LexitasLegal.com
  2. 2026-04-10 09:00 Ralph S. Baric open
    So the paper did a comparison of the effectiveness of remdisivir against two HIV drugs, lopinavir and another drug, which I'm blanking on. There had been several reports by Chinese researchers that the second drug was effective in treating SARS coronavirus. Personally, again, I'd have to reread the papers. I haven't read them in years. But my recollection is that the papers compared the treatment of this HIV therapy to historic controls. And so they didn't have as many males in the study, in the two comparisons. Males have more severe disease, so it looked like this HIV therapy was effective. It was ritonavir, the other drug. And so the Chinese were planning on using massive treatment regiments in their population, using this HIV therapy, and the paper clearly shows that that therapy doesn't work.
  3. 2026-04-10 09:00 Christina Salazar open
    They were going to use it on what?
  4. 2026-04-10 09:00 Ralph S. Baric open
    Humans.
  5. 2026-04-10 09:00 Christina Salazar
    But for all coronaviruses? For flu?
  6. 2026-04-10 09:00 Ralph S. Baric open
    Their cases of SAR-2, of COVID-19, in January of 2020.
  7. 2026-04-10 09:00 Christina Salazar open
    So they were already publishing a paper.
  8. 2026-04-10 09:00 Ralph S. Baric open
    No.
  9. 2026-04-10 09:00 Christina Salazar open
    Okay. I just want to make sure I understand. DC.Scheduling@LexitasLegal.com

Full conversation →